Members | Facebook | Twitter
URI SSHP Mentorship Program:
Support and Connect with URI Student Pharmacists!
Lauren Fortier; the student liaison for RISHP and SSHP; is attempting to restart a mentorship program to help increase engagement of RISHP pharmacist membership with SSHP student pharmacists within the URI College of Pharmacy.
The goal would be to help foster relationships between students and professionals who have similar career interests. The mentorship program will also assist in encouraging professional development and networking amongst members to the next generation of pharmacists.
Once the survey has been completed; an email will be sent to those willing to participate as a mentor with your assigned mentee; with a potential networking event in the near future.
The link is attached below; any questions please reach out to: email@example.com
Please consider taking the survey by May 6th, 2022
Take The Survey!
URI ASHP Midyear Student Posters
Attending the 2021 ASHP 2021 Midyear Meeting? Be sure to stop in and check out our URI student poster presentations on Thursday, December 9th!
Lee J, Parker H, Ackerbauer K, Feeney M. Incidence of Acute Pancreatitis in Adult COVID-19 Patients Receiving Greater than 24 Hours of Propofol.
Camara E, Sheridan G, Ranucci S, Tutalo R, Mercurio D. Evaluating the Use of Sulfonylureas in Older Adults Patients within the Integra Accountable Care Organization (ACO). American Society of Healthy-System Pharmacists.
Bleick C, Lesniak K, Miller C, McGee S, Delvecchio E, Fielder A, LaPlante K, Feret B. Enhancing Adult Pneumococcal Vaccination Practice through Educational Academic Detailing Program in Rhode Island and Massachusetts Community Pharmacies.
Burkett MD, Bratberg JP. Examining Pharmacists’ Attitudes about Scope of Practice Legislation and Real-World Implementation: A Novel Focus Group Study on Advocacy.
Boda M, Brothers T, Al-Mamun M. Evaluation of Seizure-Lowering Medication Use in the Intensive Care Unit Setting.
Hadcock CD, Lopes VV, Caffrey AR. Sugammadex and serious cardiac adverse events: a retrospective case-non-case pharmacovigilance study.
Sano U, Eisenhower C. Evaluating Preparedness of Pharmacy Students to Recognize Prescribing Cascades in Clinical Settings.
Dansereau A, Marti K, Gray M, Pugliese N. Evaluation of the Safety and Efficacy of Peripheral Vasopressors to Decrease Central Line Placement and Associated Bloodstream Infections.
Daniell J, Mcgill B, Ahearn P, Cheung C, Albano J, Gray M, Ammar M. Medication Use Evaluation of Ketamine for Sedation and Analgesia in Mechanically Ventilated Patients.
Farrell J, Brothers T, Al Mamun M. Correlation and Severity of Acute Kidney Injury and Anti-infective Use in the Critical Care Setting.
Aneesha Bhatia, Meredith McCafee. Review of current guidelines for hormonal therapy of transgender patients. American Society of Health-System Pharmacists.
Bolger C. Assessing the Study Design and Generalizability of Clinical Trials of Aducanumab and Monoclonal Antibodies in Alzheimer’s Disease.
Ventres J, Chatowsky M, Goddard H, Brown BR. Comparison of Trastuzumab and Trastuzumab with Pertuzumab in the Achievement of pCR in Early HER2+ Breast Cancer.
Chatowsky MJ. Nephrotoxicity with Ondansetron: Analysis of the US FDA Adverse Event Reporting System (FAERS).
Lerner L, Garde L, Willoughby I, Mecadon, K, Palmisciano L. Implementation of a Value-impact Dashboard for Pharmacist Care of Patients Post Kidney Transplantation.
We are seeking nominations for our various RISHP Awards which are presented at our Installation Dinner. A description of the awards can be found here.
This is a great opportunity to recognize your peers for the work they do!
It’s that time of year to solicit nominations for the various RISHP awards and 2022 vacant RISHP Board positions.
The vacant positions for 2022 include the following:
Nomination names for the above mentioned positions can be submitted to Mark Rogers (Mark.Rogers@LMHOSP.ORG) and Shannon Levesque (SMLevesque@KentRI.org). The deadline for submission of board nominations is Wednesday, October 13th.
Additionally, we are seeking nominations for our various RISHP Awards which are presented at our Installation Dinner. A description of the awards can be found here.
We are all aware of the ongoing efforts to create a COVID-19 vaccine or vaccines and that one or more may become available within the next several months. As a result, there is an abundance of information now circulating on how to prepare for the vaccination process.
The Rhode Island Department of Health (RIDOH) has created a COVID-19 Vaccine Subcommittee. The Subcommittee has two pharmacist members – Kerry LaPlante, Pharm.D. from URI and a RISHP member and Eugenio Fernandez, Pharm.D., a member of RIPA from Asthenis Pharmacy. This Subcommittee has been reaching out to hospitals, RISHP and RIPA within the State to assist with the vaccination plan.
Part of that plan has included referencing the CDC COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations. A link has been included here.
Members of the RISHP Board became acutely aware last week of two pharmacist-specific sections within the “Playbook”. Those two sections are Section 5 and Appendix F. The most concerning issue to pharmacists is the statement within Appendix F “the licensed pharmacist must complete a minimum of two hours of ACPE-approved, immunization-related continuing pharmacy education during each State licensing period” .
The RISHP Board of Directors has taken the following actions on behalf of our members:
We will continue to share information with the membership as quickly as it is received. We would also like each member to consider how they may be able to assist in upcoming vaccination efforts through-out the State. A survey is being planned.
It’s that time of year to solicit nominations for the various RISHP awards and 2021 vacant RISHP Board positions.
The vacant positions for 2021 include the following:
Nomination names for the above mentioned positions can be submitted to Karen Nolan (firstname.lastname@example.org) or Mark Rogers (Mark.Rogers@LMHOSP.ORG). The deadline for submission of board nominations is Friday, October 2nd.
Additionally, we are seeking nominations for our various RISHP Awards which are presented at our Installation Dinner. A description of the awards can be found here. Health System Pharmacist of the Year nomination letters should be forwarded to Ruth Dapaah-Afriyie ( rdapaahafriyie@Lifespan.org). All other award nominations can be forwarded to Karen Nolan or Mark Rogers. The deadline for submission of award nominations is Wednesday, October 14th
Two additional free CE's are being hosted by RISHP:
Tuesday, June 23 2020 12-1pmLunch & Learn 006 – Methodology & Interpretation of Early Phase Oncology Clinical TrialsMark Sorial, PharmD, PGY2 Hematology/Oncology Pharmacy Resident, Rhode Island HospitalRegistration Link:https://attendee.gotowebinar.com/register/3468854040153915662
Thursday, June 25 2020 12-1pm
Lunch & Learn 007 – Pediatric Medication Errors & Non Vitamin K Antagonist Oral Anticoagulants for Venous ThromboembolismErin Dudolevitch, PharmD, PGY1 Pharmacy Practice Resident, Rhode Island HospitalMichael Consaga, PharmD, PGY1 Pharmacy Practice Resident, Rhode Island HospitalRegistration Link:https://attendee.gotowebinar.com/register/3412469984066802192
Each year RI delegates present policy recommendations on behalf of RISHP members for inclusion into ASHP national policies. This is your chance to guide policy creation that impacts the future of our profession. Click on the link below to review the policies and provide feedback!
Details on each award can be found here: Awards
Congratulations to all of our winners announced at the 2020 RISHP Installation Dinner!
Pharmacist of the Year: Michelle Kelley
Resident of the Year: Melissa (Missy) Riester
Technician of the Year: Paula Robenhymer
Bill Pires New Practitioner: Ashley Rimay
Bob Goulet Student Scholarship: Lauren Dodd
Louis P Jeffrey Student Scholarship: Anne Dionne
Edward Gilberti Student Scholarship: Brooke Szachnowicz
Rhode Island Board of Pharmacy released emergency pharmacy regulations effective 04/27/2020 for a duration of 180 days. Scroll below or Click here to review the emergency regulations in their entirety, some key elements include:
For website issues issues, please click here